Not applicableStudy completedNCT03242083What this trial is testingEvaluate the Quality of Life of Patients With AMDWho this might be right forAge-related Macular Degeneration Centre Hospitalier Universitaire Dijon 28
Testing effectiveness (Phase 2)Study completedNCT00447954What this trial is testingAn Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular DegenerationWho this might be right forNonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage Neurotech Pharmaceuticals 53
Not applicableStudy completedNCT04723160What this trial is testingComputer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus PhotographWho this might be right forDiabetic RetinopathyRetinal Vein OcclusionRetinal Artery Occlusion+10 more Visionary Intelligence Ltd. 748
Testing effectiveness (Phase 2)Active Not RecruitingNCT05839041What this trial is testingA Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)Who this might be right forGeographic Atrophy of the MaculaMacular Degeneration Aviceda Therapeutics, Inc. 300
Testing effectiveness (Phase 2)Looking for participantsNCT06659549What this trial is testingEfficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMDWho this might be right forGeographic Atrophy of the Macula Galimedix Therapeutics Inc 110
Not applicableStudy completedNCT00879671What this trial is testingEffects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients With Age-related Macular DegenerationWho this might be right forAge-Related Macular Degeneration Medical University of Vienna 126
Not applicableStudy completedNCT00564902What this trial is testingThe Zeaxanthin and Visual Function StudyWho this might be right forAge Related Macular DegenerationCognition Disorders Chrysantis, Inc. 60
Not applicableLooking for participantsNCT06662162What this trial is testingMicrocurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular DegenerationWho this might be right forAge-Related Macular DegenerationAge-related Macular Degeneration (ARMD)Intermediate AMD+1 more i-Lumen Scientific AUS PTY LTD 100
Not applicableLooking for participantsNCT06351657What this trial is testingPersonalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease ProgressionWho this might be right forAge-Related Macular DegenerationGeographic Atrophy Medical University of Vienna 200
Testing effectiveness (Phase 2)Study completedNCT02140151What this trial is testingProphylactic Ranibizumab for Exudative Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration Southern California Desert Retina Consultants, MC 108
Not applicableStudy completedNCT02051998What this trial is testingDirectional Spread in Geographic AtrophyWho this might be right forNonexudative Age-related Macular Degeneration University Hospital, Bonn 130
Not applicableStudy completedNCT02264938What this trial is testingDrusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants SupplementationWho this might be right forMacular Degeneration Germans Trias i Pujol Hospital 35
Testing effectiveness (Phase 2)Study completedNCT00940407What this trial is testingToronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular DegenerationWho this might be right forNonexudative Age-related Macular Degeneration Merry, Graham, M.D. 18
Not applicableActive Not RecruitingNCT04676854What this trial is testingRestoration of Central Vision With the PRIMA System in Patients With Atrophic AMDWho this might be right forGeographic Atrophy Science Corporation 38
Not applicableLooking for participantsNCT05706896What this trial is testingAtrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich PlasmaWho this might be right forDry Age-related Macular Degeneration Fondazione Policlinico Universitario Agostino Gemelli IRCCS 36
Large-scale testing (Phase 3)Ended earlyNCT01601483What this trial is testingEfficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular DegenerationWho this might be right forNonexudative Age Related Macular Degeneration MacuCLEAR, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT05703867What this trial is testingTranspalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular DegenerationWho this might be right forAge-Related Macular DegenerationNonexudative Age-related Macular Degeneration Jarding, John, OD 404
Early research (Phase 1)Study completedNCT01922128What this trial is testingSafety Study of a Topical Treatment for Dry Age Related Macular DegenerationWho this might be right forNonexudative Age-related Macular Degeneration MacuCLEAR, Inc. 20
Not applicableStudy completedNCT05447650What this trial is testingMicrocurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT)Who this might be right forAge-Related Macular DegenerationDry Age-related Macular DegenerationNonexudative Age-related Macular Degeneration i-Lumen Scientific, Inc. 95
Not applicableStudy completedNCT04084587What this trial is testingVisual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular DegenerationWho this might be right forMacular Degeneration AdvancedMacular Degeneration, SenileMacular Degeneration, Dry+2 more University of Modena and Reggio Emilia 24